Early research (Phase 1)Not Yet RecruitingNCT07424222
What this trial is testing
Ruxolitinib for Immune Effector Cell Associated Hemophagocytic Lymphohistiocytosis-like Syndrome (RISE)
Who this might be right for
Immune Effector Associated Hemophagocytic Lymphohistiocytosis-like Syndrome (IEC-HS)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 16